National Tay-Sachs & Allied Diseases Association Receives U.S. Orphan Drug Designation for Novel Gene Therapy
September, 2009From National Tay-Sachs & Allied Diseases Association$3.5 MILLION NIH GRANT ADVANCES BID TO CURE TAY-SACHS DISEASEThe National Institutes of Health has awarded a $3.5- million grant to the Tay-Sachs Gene Therapy Consortium to continue research that may halt the fatal genetic disorder.Read more (PDF)April, 2008
From Auburn University Research News:
AU researchers work with consortium to find a cure for Tay-Sachs disease
by Heather Finch
Auburn University researchers in the College of Veterinary Medicine and Scott-Ritchey Research Center have joined researchers from Boston College, the University of Cambridge (UK) and Massachusetts General Hospital/Harvard Medical School to find a cure for Tay-Sachs disease.
February 14, 2008
From The Boston College Chronicle:
BC Researchers Aid Effort to End Tay-Sachs Disease
by Ed Hayward
Researchers from Boston College, Massachusetts General Hospital, Cambridge University (UK) and Auburn University have formed the Tay-Sachs Gene Therapy Consortium, with a goal of advancing to human clinical trials a unique gene therapy with the potential to halt the fatal genetic disorder.